ReviewClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
The Incidence and Risk Factors Associated with In-Hospital Pressure Ulcer Development After Peripheral Vascular Thrombolysis Surgery.
Review in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveA large national database was conducted to examine in-hospital pressure ulcer(PU) development in patients who underwent peripheral thrombolysis and identify potential risk factors.SourceA cohort of 120 744 adult patients from 2010 to 2019 was included in this study.MethodsThis retrospective analysis employed univariate and multivariate logistic regression analyses to examine the relationship between patient/hospital characteristics and the occurrence of PU in individuals who underwent peripheral thrombolysis. Patient factors considered included age, sex, race, comorbidities and complications, while hospital-level factors encompassed length of stay, cost, insurance type, bed size, admission type, hospital type, geographic location, and in-hospital mortality.ResultsOverall, 2.30% of patients developed PU. The rate of PU development varied annually between 2010 and 2019. Patients with PU were more likely to be non-elective admissions, hospitalized in northeastern regions, and insured by government programs rather than private insurance. PU development following peripheral vascular thrombolysis was linked to increased complications, higher healthcare costs, prolonged hospital stays, and elevated mortality rates. Patients with multiple comorbidities (three or more), chronic kidney disease, heart failure, anemia, weight loss, electrolyte imbalances, peripheral vascular disease, neurological disorders, and paraplegia were found to raise the risk of PU development. In addition, PU were associated with wound infection, wound dehiscence, pneumonia, urinary tract infection,bacteremia,cellulitis complications.ConclusionOur study unveiled the risk factors associated with the formation of in-hospital PU in patients receiving peripheral vascular thrombolysis therapy, in order to provide targeted prevention and improve management effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.